跳至主要内容
临床试验/CTRI/2021/01/030623
CTRI/2021/01/030623已完成2 期

Efficacy of Kantkateryadi Vati and Nishamalaki Vati in the management of Madhumeha w.s.r. to Type 2 Diabetes - An open labeled randomized comparative clinical trial.

Institute for Post Graduate Teaching and Research in Ayurveda0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Metabolically stable Type 2 Diabetes with signs and symptoms of Madhumeha (Type 2 Diabetes) as mentioned in clinical study will be selected from O.P.D. and I.P.D. of IPGT and RA Hospital, Jamnagar.
  • 2. Newly diagnosed cases will be included for the study.
  • 3.Classical signs and symptoms of Madhumeha ââ?¬â?? Suptata, Karpaddaha, Prabhuta Mutrata, Daurbalya, Chumchumayana.
  • 4.Fasting plasma glucose ââ?°Â¥ 126 mg/dl to 200 mg/dl and Post Prandial glucose level ââ?°Â¥ 200 mg/dl to 300 mg/dl.

排除标准

  • 1. Patientââ?¬•s age below 18 years and above 70 years.
  • 2.Patients with other metabolic and endocrine disorders.
  • 3.Patients having Fasting plasma glucose >200 mg/dl and Post Prandial glucose level
  • >300 mg/dl.
  • 4.Patients having any other malignancies, any other serious illness.
  • 5.Patients with diabetic wound / ulcers.
  • 6.Patients of Diabetes mellitus receiving Insulin.
  • 7.Patients having chronic complications of Type 2 Diabetes.
  • 8.Micro vascular: Retinopathy, Neuropathy and Nephropathy.
  • 9.Macro vascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
  • 10.Other chronic debilitating disease like STD etc.
  • 11.Pregnant and lactating women.

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda

相似试验